BioAge Labs (BIOA) Cash from Operations (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Cash from Operations data on file, last reported at 24046000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 38.49% year-over-year to 24046000.0; the trailing twelve-month figure through Mar 2026 stood at 88310000.0 (down 65.96% YoY), and the FY2025 full-year result was 81627000.0, down 58.43% from the prior year.
• Cash from Operations grew to 24046000.0 in Q1 2026, from 28251000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 5138000.0 in Q4 2024 to a low of 28251000.0 in Q4 2025.
• A 4-year average of 16569800.0 and a median of 15912500.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 39.57% in 2024 and slumped 449.84% in 2025, its largest moves.
• Tracing BIOA's Cash from Operations over 4 years: stood at 8503000.0 in 2023, then soared by 39.57% to 5138000.0 in 2024, then tumbled by 449.84% to 28251000.0 in 2025, then advanced by 14.88% to 24046000.0 in 2026.
• Business Quant data shows BIOA's Cash from Operations at 24046000.0 in Q1 2026, 28251000.0 in Q4 2025, and 16044000.0 in Q3 2025.